HealthLeaders Media November 18, 2022
In a letter to CMS, lawmakers highlight five steps they want the agency to take to counter deceptive practices.
U.S. senators have asked CMS to take action to protect beneficiaries from harmful Medicare Advantage (MA) marketing tactics through further oversight and regulations.
Thirteen senators penned a letter to the agency outlining five changes CMS can make through notice and comment rulemaking and sub-regulatory guidance as soon as possible.
The letter comes after the Senate Finance Committee’s investigation into MA marketing practices, which found a “concerning pattern of misleading advertising materials, aggressive marketing tactics, and in some cases flat-out deception harmful to beneficiary access to care and health outcomes,” the senators wrote.
Complaints over MA marketing are not new, with the...